Voriconazole-Induced Pancreatitis Despite Therapeutic Trough Concentrations During Treatment of Disseminated Fusariosis in a Hospitalized Patient. (PubMed, Am J Case Rep) - Aug 24, 2026 - "He was initially treated with amphotericin B and isavuconazonium, then transitioned to voriconazole for targeted antifungal therapy. CONCLUSIONS This case highlights voriconazole-induced pancreatitis as a clinically important adverse event that may occur despite therapeutic drug levels. Early recognition and prompt drug discontinuation can lead to rapid clinical recovery and allow for transition to alternative antifungal therapy."
Journal • Acute Myelogenous Leukemia • Dyslipidemia • Endocrine Disorders • Gastroenterology • Hematological Disorders • Hematological Malignancies • Hypertriglyceridemia • Infectious Disease • Leukemia • Metabolic Disorders • Myelodysplastic Syndrome • Oncology • Pain • Pancreatitis • Severe Hypertriglyceridemia
|
|
Brunelda Aristilde; Kin F Fentie; Libardo Rueda Prada; Marta E Berguido de la Guardia; Michael Evans
|